Design Therapeutics, Inc.
DSGN
$9.77
$0.839.28%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -67.45M | -63.49M | -56.20M | -49.59M | -47.78M |
| Total Depreciation and Amortization | 615.00K | 613.00K | 612.00K | 596.00K | 585.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 10.82M | 9.66M | 7.90M | 6.88M | 5.74M |
| Change in Net Operating Assets | 3.76M | 2.58M | 233.00K | -993.00K | -4.59M |
| Cash from Operations | -52.25M | -50.64M | -47.46M | -43.11M | -46.04M |
| Capital Expenditure | -159.00K | -143.00K | -217.00K | -340.00K | -367.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 36.49M | 24.14M | 31.43M | 44.30M | 48.05M |
| Cash from Investing | 36.33M | 23.99M | 31.21M | 43.96M | 47.68M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 684.00K | 648.00K | 516.00K | 513.00K | 751.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 684.00K | 648.00K | 516.00K | 513.00K | 751.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -15.24M | -26.00M | -15.73M | 1.36M | 2.39M |